ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,859Medicare Part D Prescriptions Filled, Including Refills

Rank: 557 out of 4623

$444K Total Retail Price of All Prescriptions

Rank: 905 out of 4623

478 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 478 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

18% of this provider’s 478 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 7,703 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LOVASTATIN 378 310 1 34
OMEPRAZOLE 371 253 2 7
HYDROCODONE-ACETAMINOPHEN 357 296 S3 3 3
FUROSEMIDE 321 291 4 8
POTASSIUM CHLORIDE 318 271 5 14
LISINOPRIL 310 269 6 4
LEVOTHYROXINE SODIUM 307 273 7 1
HYDROCHLOROTHIAZIDE 297 269 8 10
SIMVASTATIN 280 233 9 2
GABAPENTIN 254 179 10 16
AMLODIPINE BESYLATE 198 179 11 5
METOPROLOL SUCCINATE 176 173 12 13
METFORMIN HCL 157 133 13 6
ZOLPIDEM TARTRATE 156 133 14 18
WARFARIN SODIUM 146 129 15 24
ALENDRONATE SODIUM 141 107 16 22
DOXAZOSIN MESYLATE 134 119 17 98
ATENOLOL 123 107 18 28
SERTRALINE HCL 119 68 19 26
TRAZODONE HCL 118 94 20 42
TAMSULOSIN HCL 111 92 21 29
FLUOXETINE HCL 106 70 22 61
FENTANYL 102 69 S2 23 118
CITALOPRAM HBR 100 90 24 23
ETODOLAC 99 73 25 160
METOPROLOL TARTRATE 98 74 26 9
FENOFIBRATE 96 43 27 54
PAROXETINE HCL 89 65 28 78
LOSARTAN POTASSIUM 88 74 29 21
ATORVASTATIN CALCIUM 84 76 30 12
TRAMADOL HCL 83 61 31 15
OXYBUTYNIN CHLORIDE 77 71 32 120
POLYETHYLENE GLYCOL 3350 74 49 33 91
FLUTICASONE PROPIONATE 72 52 34 32
ADVAIR DISKUS 70 51 35 62
GEMFIBROZIL 64 49 36 94
ENALAPRIL MALEATE 63 39 37 41
PLAVIX 62 62 38 45
CLOPIDOGREL 59 56 39 31
VENLAFAXINE HCL ER 55 18 40 132
ALLOPURINOL 51 50 41 37
GLYBURIDE 50 30 R 42 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.